JPMorgan Chase & Co’s VYNE Therapeutics VYNE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $241 | Sell |
146
-5,835
| -98% | -$9.63K | ﹤0.01% | 5879 |
|
|
2025
Q1 | $9.45K | Buy |
5,981
+5,667
| +1,805% | +$8.95K | ﹤0.01% | 5454 |
|
|
2024
Q4 | $1.05K | Buy |
314
+137
| +77% | +$459 | ﹤0.01% | 5667 |
|
|
2024
Q3 | $332 | Buy |
177
+1
| +0.6% | +$2 | ﹤0.01% | 5774 |
|
|
2024
Q2 | $347 | Buy |
176
+7
| +4% | +$14 | ﹤0.01% | 5699 |
|
|
2024
Q1 | $520 | Buy |
169
+23
| +16% | +$71 | ﹤0.01% | 5698 |
|
|
2023
Q4 | $341 | Hold |
146
| – | – | ﹤0.01% | 5943 |
|
|
2023
Q3 | $584 | Buy |
146
+138
| +1,725% | +$552 | ﹤0.01% | 5743 |
|
|
2023
Q2 | $32 | Hold |
8
| – | – | ﹤0.01% | 5858 |
|
|
2023
Q1 | $0 | Sell |
8
-2
| -20% | – | ﹤0.01% | 6141 |
|
|
2022
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 5959 |
|
|
2022
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 5849 |
|
|
2022
Q2 | $0 | Sell |
10
-282
| -97% | – | ﹤0.01% | 5931 |
|
|
2022
Q1 | $3K | Buy |
292
+283
| +3,144% | +$2.91K | ﹤0.01% | 5561 |
|
|
2021
Q4 | $0 | Sell |
9
-201
| -96% | – | ﹤0.01% | 5932 |
|
|
2021
Q3 | $5K | Sell |
210
-402
| -66% | -$9.57K | ﹤0.01% | 5315 |
|
|
2021
Q2 | $38K | Sell |
612
-3,712
| -86% | -$230K | ﹤0.01% | 5010 |
|
|
2021
Q1 | $533K | Sell |
4,324
-3,894
| -47% | -$480K | ﹤0.01% | 4010 |
|
|
2020
Q4 | $935K | Buy |
8,218
+2,462
| +43% | +$280K | ﹤0.01% | 3417 |
|
|
2020
Q3 | $683K | Buy |
5,756
+403
| +8% | +$47.8K | ﹤0.01% | 3262 |
|
|
2020
Q2 | $667K | Sell |
5,353
-362
| -6% | -$45.1K | ﹤0.01% | 3190 |
|
|
2020
Q1 | $1.1M | Sell |
5,715
-1,134
| -17% | -$219K | ﹤0.01% | 2896 |
|
|
2019
Q4 | $2.29M | Sell |
6,849
-572
| -8% | -$191K | ﹤0.01% | 2625 |
|
|
2019
Q3 | $2.39M | Sell |
7,421
-983
| -12% | -$317K | ﹤0.01% | 2633 |
|
|
2019
Q2 | $3.36M | Sell |
8,404
-356
| -4% | -$143K | ﹤0.01% | 2358 |
|
|
2019
Q1 | $4.95M | Sell |
8,760
-1,176
| -12% | -$665K | ﹤0.01% | 2104 |
|
|
2018
Q4 | $2.95M | Buy |
9,936
+1,645
| +20% | +$488K | ﹤0.01% | 2421 |
|
|
2018
Q3 | $5.88M | Buy |
8,291
+6,510
| +366% | +$4.62M | ﹤0.01% | 2145 |
|
|
2018
Q2 | $1.04M | Buy |
1,781
+181
| +11% | +$106K | ﹤0.01% | 3127 |
|
|
2018
Q1 | $4.33M | Buy |
+1,600
| New | +$4.33M | ﹤0.01% | 2302 |
|